SYMBICORT® in the Treatment of COPD

Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients

NCT01921127 ·Status: COMPLETED

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

NCT00542880 ·Status: COMPLETED ·Phase: PHASE4

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients

NCT02093195 ·Status: UNKNOWN ·Phase: PHASE2

A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

NCT00419744 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan

NCT01070784 ·Status: COMPLETED ·Phase: PHASE3

Phase IV O2 Consumption Study in COPD Patients.

NCT02533505 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01069289 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD

NCT00489853 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

NCT00206167 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00837629 ·Status: COMPLETED

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

NCT00421122 ·Status: COMPLETED ·Phase: PHASE3

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

NCT00291408 ·Status: WITHDRAWN ·Phase: PHASE4

Adherence Study in COPD Patients

NCT02864342 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

NCT03262012 ·Status: COMPLETED ·Phase: PHASE3

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo

NCT01760304 ·Status: TERMINATED ·Phase: PHASE4

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01205269 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)

NCT02497001 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD

NCT02766608 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01415518 ·Status: COMPLETED ·Phase: PHASE4

Effect of Symbicort ® on GR in Sputum in COPD

NCT01787097 ·Status: COMPLETED ·Phase: PHASE4

Effects of Symbicort on the Ventilatory Kinematics

NCT01712854 ·Status: TERMINATED ·Phase: PHASE4

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

NCT00206154 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00929708 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease

NCT01391559 ·Status: COMPLETED ·Phase: NA

A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota

NCT02833480 ·Status: UNKNOWN ·Phase: PHASE2